Pro Share Advisors LLC Bio Techne Corp Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 21,491 shares of TECH stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,491

Previous 23,170 7.25%

Holding current value

$1.53 Million

Previous $1.66 Million 3.43%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$70.96 - $82.35 $119,141 - $138,265	-1,679 Reduced 7.25%	21,491 $1.72 Million
Q2 2024 Aug 13, 2024	SELL	$62.12 - $84.15 $138,465 - $187,570	-2,229 Reduced 8.78%	23,170 $1.66 Million
Q1 2024 May 08, 2024	SELL	$65.98 - $77.09 $50,276 - $58,742	-762 Reduced 2.91%	25,399 $1.79 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $108,037 - $159,959	-2,045 Reduced 7.25%	26,161 $2.02 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $88,991 - $117,855	-1,318 Reduced 4.46%	28,206 $1.92 Million
Q2 2023 Aug 10, 2023	SELL	$73.76 - $85.98 $10,547 - $12,295	-143 Reduced 0.48%	29,524 $2.41 Million
Q1 2023 May 11, 2023	BUY	$71.62 - $86.62 $603,040 - $729,340	8,420 Added 39.63%	29,667 $2.2 Million
Q4 2022 Feb 02, 2023	BUY	$80.67 - $352.29 $1.28 Million - $5.61 Million	15,917 Added 298.63%	21,247 $1.76 Million
Q3 2022 Nov 04, 2022	SELL	$282.54 - $391.85 $174,327 - $241,771	-617 Reduced 10.37%	5,330 $1.52 Million
Q2 2022 Aug 01, 2022	SELL	$322.67 - $449.65 $760,533 - $1.06 Million	-2,357 Reduced 28.38%	5,947 $2.06 Million
Q1 2022 May 10, 2022	SELL	$353.85 - $487.79 $81,739 - $112,679	-231 Reduced 2.71%	8,304 $3.6 Million
Q4 2021 Feb 08, 2022	BUY	$456.15 - $525.06 $905,913 - $1.04 Million	1,986 Added 30.33%	8,535 $4.42 Million
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $981,828 - $1.19 Million	2,207 Added 50.83%	6,549 $3.17 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $243,255 - $282,763	628 Added 16.91%	4,342 $1.96 Million
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $943 - $1,233	-3 Reduced 0.08%	3,714 $1.42 Million
Q4 2020 Feb 09, 2021	SELL	$246.9 - $321.87 $1.42 Million - $1.85 Million	-5,761 Reduced 60.78%	3,717 $1.18 Million
Q3 2020 Nov 13, 2020	BUY	$232.22 - $282.96 $52,713 - $64,231	227 Added 2.45%	9,478 $2.35 Million
Q2 2020 Aug 03, 2020	BUY	$185.43 - $279.56 $352,873 - $532,002	1,903 Added 25.9%	9,251 $2.44 Million
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $811,329 - $1.12 Million	-5,034 Reduced 40.66%	7,348 $1.39 Million
Q4 2019 Feb 12, 2020	SELL	$189.68 - $222.09 $316,955 - $371,112	-1,671 Reduced 11.89%	12,382 $2.72 Million
Q3 2019 Nov 12, 2019	SELL	$183.56 - $216.72 $170,160 - $200,899	-927 Reduced 6.19%	14,053 $2.75 Million
Q2 2019 Aug 13, 2019	SELL	$188.72 - $215.43 $469,157 - $535,558	-2,486 Reduced 14.23%	14,980 $3.12 Million
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $142,894 - $210,462	1,050 Added 6.4%	17,466 $3.47 Million
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $453,739 - $696,588	-3,418 Reduced 17.23%	16,416 $2.38 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $7,519 - $10,409	-51 Reduced 0.26%	19,834 $4.05 Million
Q2 2018 Aug 13, 2018	SELL	$144.9 - $165.58 $226,913 - $259,298	-1,566 Reduced 7.3%	19,885 $2.94 Million
Q1 2018 May 14, 2018	SELL	$131.46 - $151.04 $391,356 - $449,646	-2,977 Reduced 12.19%	21,451 $3.24 Million
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $15,873 - $17,652	131 Added 0.54%	24,428 $3.17 Million
Q3 2017 Nov 13, 2017	BUY	$113.59 - $123.78 $201,054 - $219,090	1,770 Added 7.86%	24,297 $2.94 Million
Q2 2017 Aug 11, 2017	BUY	N/A	22,527	22,527 $2.65 Million

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Bio Techne Corp Transaction History